课题基金 / 基金详情

项目摘要

项目成果

XUDONG J. LI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):症状性椎间盘退变似乎是慢性腰背部症状最常见的原因之一。尽管包括手术切除和组织工程在内的治疗技术已经被应用/提出,但椎间盘退变的治疗仍然是临床医生和基础科学家面临的一个巨大挑战。氧化应激被认为在椎间盘退变过程的早期阶段起重要作用。然而,在椎间盘退变的治疗中,使用抗氧化剂的治疗策略一直被忽视,特别是富勒烯及其衍生物对椎间盘退变的影响还没有发表的报道。该项目的目的是表征一种特定的富勒烯C60衍生物,双甲基膦酸富勒烯(BMPF)的水溶液在体外和体内对椎间盘退行性改变的抑制作用,假设它们可能非常有效地治疗椎间盘退变。用富勒烯及其衍生物BMPF和C60、一种单甲基膦酸富勒烯、一种富勒烯醇和两种羧基富勒烯制备纳米颗粒悬浮液。研究其对过氧化氢或IL-1诱导的体外培养人椎间盘细胞凋亡和基质破坏的保护作用。它们对椎间盘退变的抑制作用将通过兔环针穿刺模型进一步评估。目前涉及化学、材料科学和生物医学的研究将为椎间盘退变的治疗策略提供有用的线索,并可能为椎间盘退变的治疗提供一些新的潜在候选药物。
英文摘要
DESCRIPTION (provided by applicant): Symptomatic intervertebral disc degeneration appears to be one of the most prevalent causes of chronic low back symptoms. Although therapeutic techniques including surgical removal and tissue engineering have been applied/proposed, the treatment of disc degeneration still remains a great challenge to both clinical physicians and basic scientists. Oxidative stress is regarded to play an important role in the early stages of disc degenerative process. However, therapeutic strategies using antioxidative agents have been ignored in the treatment of disc degeneration, and in particular, there are no reports on the effects of fullerene and its derivatives on disc degeneration published. The aim of the project is to characterize the inhibitory effects of aqueous solutions of a specific fullerene C60 derivative, bis- methanophosphonate fullerene (BMPF) on degenerative changes of intervertebral disc in vitro and in vivo based on the hypothesis that they might be very effective in the treatment of disc degeneration. Aqueous nanoparticle suspension will be prepared from fullerene and its derivatives including BMPF and C60, a mono- methanophosphonate fullerene, a fullerol and two carboxyfullerenes. Their protective activities against apoptosis and matrix destruction of cultured human disc cells induced by hydrogen peroxide or IL-1 will be investigated. Their inhibitory effects on disc degeneration will be further evaluated by using a rabbit annulus needle puncture model. The present study involving chemical, materials science and biomedicine will provide useful clues to the therapeutic strategy of disc degeneration and possibly lead to some novel potential candidates for the treatment of disc degeneration. PUBLIC HEALTH RELEVANCE: Aqueous nanoparticle suspensions of a fullerene derivative, bis- methanophosphonate fullerene will be prepared by different methods and their protective oxidative scavenging effects will be investigated against apoptotic and matrix destructive changes in the intervertebral disc both in vitro and in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering Macrophage Phenotype and Function in Disc Herniation and associated Back/leg Pain
  • 批准号:
    10364328
  • 项目类别:
  • 资助金额:
    $48.09万
  • 财政年份:
    2022
  • 负责人:
    XUDONG J. LI
  • 依托单位:
Deciphering Macrophage Phenotype and Function in Disc Herniation and associated Back/leg Pain
  • 批准号:
    10598460
  • 项目类别:
  • 资助金额:
    $47.15万
  • 财政年份:
    2022
  • 负责人:
    XUDONG J. LI
  • 依托单位:
An ex vivo system to model the inflammatory microenvironment of human disc herniation
  • 批准号:
    10302594
  • 项目类别:
  • 资助金额:
    $38.82万
  • 财政年份:
    2021
  • 负责人:
    XUDONG J. LI
  • 依托单位:
Disc-on-a-chip: microfluidic nutrition and biomechanical loading integrated mouse disc culture system
  • 批准号:
    9750632
  • 项目类别:
  • 资助金额:
    $21.32万
  • 财政年份:
    2018
  • 负责人:
    XUDONG J. LI
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: